Discount sale is live
Logo
Muscular Dystrophy Treatment Market
  2. / Market Insights
  3. Table of Content - Muscular Dystrophy Treatment Market Analysis
all report title image

Muscular Dystrophy Treatment Market, By Treatment Type (Gene Therapy, Exon-Skipping Therapeutics, Corticosteroids, Anti-inflammatory Drugs, Others), By Disease Type (Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb-Girdle Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy, Others), By End User (Hospitals, Specialty Clinics, Homecare Settings, Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Sep 2025
  • Code : CMI914
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
    • 역사적 범위: 2020 - 2024
    • 예측 기간: 2025 - 2032
Ingographics Image
N/A

Table of Contents

  1. Research Objectives and Assumptions

    • Research Objectives

    • Assumptions

    • Abbreviations

  2. Market Purview

    • Report Description

      • Market Definition and Scope

    • Executive Summary

      • Market Snapshot, By Treatment Type

      • Market Snapshot, By Disease Type

      • Market Snapshot, By End User

      • Market Snapshot, By Region

    • Coherent Opportunity Map (COM)

  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics

      • Drivers

      • Restraints

      • Market Opportunities

    • Impact Analysis

    • Recent Product Launches

    • Epidemiology

    • Merger, Acquisition, and Collaborations

    • Regulatory Scenario

    • Key Developments

    • PEST Analysis

    • Partnership Scenario

    • Brand and Pricing Analysis

    • Distributors Landscape

    • Porters Analysis

    • Technological Advancements

    • Key Developments

    • Market Trend

    • Future Prospective

    • Top Market Players by Revenue

  4. Muscular Dystrophy Treatment Market, By Treatment Type, 2025–2032, (US$ Million)

    • Introduction

      • Market Share Analysis, 2025 and 2032 (%)

      • Y-o-Y Growth Analysis, 2021–2032

      • Segment Trends

    • Gene Therapy

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Million)

    • Exon-Skipping Therapeutics

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Million)

    • Corticosteroids

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Million)

    • Anti-inflammatory Drugs

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Million)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Million)

  5. Muscular Dystrophy Treatment Market, By Disease Type, 2025-2032, (US$ Million)

    • Introduction

      • Market Share Analysis, 2025 and 2032 (%)

      • Y-o-Y Growth Analysis, 2021–2032

      • Segment Trends

    • Duchenne Muscular Dystrophy

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Million)

    • Becker Muscular Dystrophy

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Million)

    • Limb-Girdle Muscular Dystrophy

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Million)

    • Facioscapulohumeral Muscular Dystrophy

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Million)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Million)

  6. Muscular Dystrophy Treatment Market, By End User, 2025-2032, (US$ Million)

    • Introduction

      • Market Share Analysis, 2025 and 2032 (%)

      • Y-o-Y Growth Analysis, 2021–2032

      • Segment Trends

    • Hospitals

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Million)

    • Specialty Clinics

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Million)

    • Homecare Settings

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Million)

    • Research Institutes

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Million)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Million)

  7. Muscular Dystrophy Treatment Market, By Region, 2025-2032, (US$ Million)

    • Introduction

      • Market Share Analysis, By Region, 2025 and 2032 (%)

      • Y-o-Y Growth Analysis, For Regions, 2021–2032

      • Regional Trends

    • North America

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2025-2032, (US$ Million)

      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2025-2032, (US$ Million)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2025-2032, (US$ Million)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Million)

        • U.S.

        • Canada

    • Latin America

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2025-2032, (US$ Million)

      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2025-2032, (US$ Million)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2025-2032, (US$ Million)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Million)

        • Brazil

        • Mexico

        • Argentina

        • Rest of Latin America

    • Europe

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2025-2032, (US$ Million)

      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2025-2032, (US$ Million)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2025-2032, (US$ Million)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Million)

        • U.K.

        • Germany

        • Italy

        • France

        • Spain

        • Russia

        • Benelux

        • Denmark

        • Norway

        • Sweden

        • Rest of Europe

    • Asia Pacific

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2025-2032, (US$ Million)

      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2025-2032, (US$ Million)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2025-2032, (US$ Million)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Million)

        • China

        • Taiwan

        • India

        • Japan

        • Indonesia

        • Malaysia

        • Philippines

        • Singapore

        • Australia

        • South Korea

        • Rest of Asia Pacific

    • Middle East & Africa

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2025-2032, (US$ Million)

      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2025-2032, (US$ Million)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2025-2032, (US$ Million)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Million)

        • Bahrain

        • Kuwait

        • Oman

        • Qatar

        • Saudi Arabia

        • UAE

        • Israel

        • South Africa

        • North Africa

        • Central Africa

        • Rest of Middle East

  8. Competitive Landscape

    • Sarepta Therapeutics

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • PTC Therapeutics

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • BioMarin Pharmaceutical

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Roche Holding AG

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Pfizer Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Novartis AG

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Catalent Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Solid Biosciences

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Audentes Therapeutics (Astellas Pharma subsidiary)

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Summit Therapeutics

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

  9. Section

    • Research Methodology

    • About Us

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.